Anti-Human/Mouse/Rat MMP2 Antibody with collaborator-tested evidence for IHC.
Know who made it. See the evidence. Buy through one marketplace.
Anti-Human/Mouse/Rat MMP2 Antibody is a research-use antibody from Elabscience for studying MMP2 in IHC workflows with listed reactivity for Human, Mouse, Rat. Specifications and supporting documents below should be reviewed when planning the experiment.
Fully tested in-house by ABMIUM. Highest confidence. Non-conformities fully supported under the ABMIUM Product Promise.
Quality verified. Independent collaborator or expected-performance data available. Product meets ABMIUM quality standards.
Expected to work based on structural and biochemical data. Not yet directly tested by ABMIUM or a collaborator. No non-conformity support for this combination.
Not recommended for this application or species/sample combination. This may indicate either evidence of unsuitability or that the combination has not been tested and therefore cannot currently be recommended.
Evidence status by application and model.
| Species | WB | IHC-P | IHC-Fr | IF/ICC | Flow Cyt | IP | ChIP | IHC |
|---|---|---|---|---|---|---|---|---|
| Human | ||||||||
| Mouse | ||||||||
| Rat |
This product is manufactured by Elabscience and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
MMP2 identifies matrix metallopeptidase 2 in Homo sapiens (Human). This target record connects NCBI Gene 4313, UniProtKB P08253 and related ABMIUM catalogue products.
Biological function: MMP2 is a matrix metalloproteinase that remodels extracellular matrix and contributes to vascular remodelling, angiogenesis, tissue repair, inflammation and tumour-associated tissue invasion.
